Rory Riggs

Biomatrix, Inc. develops, manufactures, markets and sells a series of proprietary viscoelastic products called 'hylans'. Hylans are the second generation of viscoelastics used in medicine and are characterized by significantly enhanced physical properties such as elasticity, viscosity and pseudoplasticity. These products are used in therapeutic medical applications and skin care. The company was founded by Endre A. Balazs and Janet L. Denlinger in 1981 and is headquartered in Ridgefield, NJ.

Patient Choice Healthcare, Inc. provides medical health care plan and network services. The company was founded by Ann Robinow and Carl J. Schramm on December 20, 2001 and is headquartered in St. Louis Park, MN.

The RF&P Corp. provides railroad transportation services. The private company is based in Richmond, VA.

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The firm’s lead product candidate, ITI-007, is in clinical development as a first-in-class treatment for schizophrenia. It also includes pre-clinical programs that are focused on advancing drug candidates for the treatment of cognitive dysfunction, in both schizophrenia and Alzheimer's disease and for disease modification and the treatment of neurodegenerative disorders, including Alzheimer's disease. The company was founded by Paul Greengard and Sharon Mates in 2002 and is headquartered in Bedminster, NJ.

Syntax Analytics LLC provides investment advisory services. The private company is based in New York, NY. The company was founded by Rory Balfour Riggs. Rory Balfour Riggs has been the CEO since incorporation.

New Ventures I LLC seeks investment opportunities in companies across the globe. The fund targets companies operating in the fields of life sciences, healthcare and agriculture. It provides financing for early stage capital requirements.

Balfour LLC (Balfour) is an independent venture capital firm founded by Rory Riggs. The firm is headquartered in New York.

Cibus Corp. engages in the development of plant and microbial platforms. Its focuses in inputting traits and agronomic traits in canola, rice, soybean, corn, and wheat crops. The company was founded by Peter Beetham, Greg Gocal, Keith Walker, and Rory Riggs in 2001 and is headquartered in San Diego, CA.

Balfour Venture Partners provides investment advisory services. The private company is based in New York, NY.

Locus Analytics LLC was founded by Rory Riggs. The company engages in the provision of developing a new approach to organizing business and economic data and is headquartered in NY.

Syntax ETF Trust engages in the investment and trust fund services. It also handles the purchases and sale of fund shares. The company was founded on June 27, 2013 and is headquartered in New York, NY.

Nucelis Inc is a pioneering bio-technology company built on a platform of unique, patented technology for optimizing cell structure and function. Nucelis has licensed exclusive access to Rapid Trait Development System (RTDS™) technology in its' key product areas which enables precise changes in the DNA of virtually any living organism. RTDS takes advantage of the natural gene repair system which exists in all cells and is typically used by a cell to correct naturally occurring DNA mistakes and mutations. RTDS is much more precise compared to the randomness of traditional transgenic technology.

Sparton Corp. engages in the design, development, and manufacture of maritime electronic systems. Its products include sonobuoys, undersea warfare solutions, and inertial sensors. The company was founded by W. H. Withington in 1900 and is headquartered in De Leon Springs, FL.

Nuredis, Inc. develops treatments for neurodegenerative and neuromuscular diseases. The private company is based in Menlo Park, CA. The company was founded by Stanley N. Cohen.

Syntax LLC is a financial data and technology company that operates through three segments: Affinity Data™, Syntax Direct™, and Syntax Indices™. The private company is based in New York, NY and has subsidiaries in the United States. The company codifies business models into a relational system and offers the most comprehensive, granular, and accurate product line revenue data available on the market. Syntax Direct™ facilitates the creation and management of direct indexing solutions and rules-based equity portfolios through a fully automated platform. Syntax Indices™ offers customized and proprietary indices, including core benchmarks and micro- and macro-thematic, smart beta, defined outcome, and target volatility indices. The company was founded by Rory Balfour Riggs, and Patrick Shaddow has been the CEO of the company since 2021.

Strategic Planning Associates provides investment advice.

Cibus Ltd. is a biotechnology company, which engages in the research and development of plant gene editing technology. It focuses on the commercialization of proprietary gene-editing technology, which refer to as the Rapid Trait Development System (RTDS). The RTDS enables to introduce customizable, specific, and predictable value-enhancing traits into plants and microorganisms. The company was founded in 2001 and is headquartered in San Diego, CA.

Syntax Advisors LLC is a SEC-registered investment advisor headquartered in New York City. The firm was founded by Rory B. Riggs in 2009 and is a subsidiary of Syntax LLC. Syntax Advisors provides advisory services to Exchange Traded Funds (ETFs), a private investment fund and limited number of Separately Managed Accounts.

Scientia Ventures LLC (Scientia Ventures) is a venture capital firm founded in 2006 by Jonathan Finn. The firm is headquartered in New York.